Thousand Oaks-based Amgen completed its largest acquisition in company history on Oct. 6, purchasing Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion. "Today marks an exciting milestone as we welcome Horizon employees to Amgen and begin working together to serve even more patients around the world suffering from